Jonathan Goldman, MD is a professor of medicine at the David Geffen School of Medicine at University of California, Los Angeles. He specializes in lung cancer, hematology, solid tumors, and early drug development.
Peripheral Neuropathy Treatable With Teliso-V in C–Met-High NSCLC
Toxicities related to Teliso-V are manageable for patients with c-Met overexpressing non-small cell lung cancer, according to Jonathan Goldman, MD.
Relacorilant Combo Sustains Ovarian Cancer Benefit Post Platinum Break
Genomic Changes May Drive Sotorasib KRAS G12C+ Combo Resistance in CRC
Relacorilant/Nab-Paclitaxel Is Convenient, Safe in Ovarian Cancer
Neoadjuvant Nivolumab Regimen Improves OS in Resectable NSCLC